Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease

肌肉和血管疾病微生理模型中的全身炎症

基本信息

  • 批准号:
    10013428
  • 负责人:
  • 金额:
    $ 25.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-01 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The initiation and progression of atherosclerosis is influenced by systemic inflammation and individuals suffering from autoimmune diseases, such as rheumatoid arthritis, have increased risk of developing cardiovascular diseases. Likewise, chronic and systemic inflammation in rheumatoid arthritis induces muscle wasting and loss of function. Therapies that reduce inflammation effectively treat rheumatoid arthritis and have the potential to reduce the severity of cardiovascular disease. To overcome limitations of animal models replicating some key disease phenotypes, but not the underlying mechanisms, we established functional human microphysiological systems (hMPS) for healthy human skeletal and cardiac muscle and endothelialized tissue-engineered blood vessels (eTBEVs) using primary and iPS-derived cells and assessed the response to drugs and pro-inflammatory cytokines. These models replicate the structure and key functions of the native tissue and maintain their structure and function for at least 4 weeks. These in vitro tissue systems accurately model the response to drugs. Our goal in this project is to develop clinically relevant hMPS disease models to examine rheumatoid arthritis (RA) risk for muscle dysfunction and atherosclerosis and the role of exercise in attenuating disease-associated inflammation. To meet this goal, we will expand our preliminary results to develop and validate an early atherosclerosis model that uses flow conditions promoting endothelial dysfunction, macrophage accumulation, foam cell formation, and altered vasoactivity. We will reproduce the RA phenotype in skeletal and cardiac muscle through addition of macrophages and cytokines present in RA, and demonstrate that simulated exercise conditions on muscle produce myokines that reduce inflammation in this RA model. Then, we will develop an integrated perfusion system for eTEBVs, skeletal and cardiac muscle and show that the RA model can increase macrophage accumulation in eTEBVs and cardiac bundles, and assess the response to exercise and drugs to treat atherosclerosis and inflammation. We will use CRISPR gene editing technology to generate mutations to proprotein convertase subtilisin/kexin type 9 (PCSK9) and genes that affect IL-6 shedding to assess their impact on endothelial dysfunction and foam cell formation in eTEBVs, and inflammation in skeletal and cardiac muscle bundles. We will profile cytokines and metabolites in the models with and without RA, and demonstrate that disease progression and biomarkers are reduced in the presence of common anti-inflammatory therapeutic interventions for atherosclerosis, and assess the effect of exercise. Likewise, in the RA muscle model, we will examine whether gene variants produce alterations in cytokine profiles impacting muscle function and response to exercise; these may point toward new disease-associated biomarkers and therapeutic targets. Results of this project will provide a general framework for in vitro modeling of atherosclerosis and autoimmune diseases and the role of gene variants in disease severity and drug development.
摘要 动脉粥样硬化的发生和发展受全身炎症和个体的影响 患有类风湿性关节炎等自身免疫性疾病的人,患上此类疾病的风险会增加 心血管疾病同样,类风湿性关节炎中的慢性和全身性炎症诱导肌肉 浪费和功能丧失。减少炎症的疗法有效地治疗类风湿性关节炎, 有可能降低心血管疾病的严重程度。克服动物的局限性 我们建立的模型复制了一些关键的疾病表型,但不是潜在的机制, 健康人体骨骼肌和心肌的功能性人体微生理系统(hMPS), 内皮化组织工程血管(eTBEV)使用原代和iPS衍生的细胞,并评估 对药物和促炎细胞因子的反应。这些模型复制了 并保持其结构和功能至少4周。这些体外组织 系统准确地模拟了对药物的反应。我们在这个项目中的目标是开发临床相关的 hMPS疾病模型用于检查类风湿性关节炎(RA)肌肉功能障碍和动脉粥样硬化的风险 以及运动在减轻疾病相关炎症中的作用。为了实现这一目标,我们将扩大 开发和验证早期动脉粥样硬化模型的初步结果, 内皮功能障碍、巨噬细胞积聚、泡沫细胞形成和改变的血管活性。我们将 通过加入巨噬细胞和细胞因子在骨骼肌和心肌中复制RA表型 存在于RA中,并证明肌肉上的模拟运动条件产生肌因子, 在这个RA模型中。然后,我们将开发一个集成的灌注系统,用于eTEBV,骨骼 和心肌,并显示RA模型可以增加eTEBV中的巨噬细胞积累, 心脏束,并评估对运动和药物治疗动脉粥样硬化和炎症的反应。 我们将使用CRISPR基因编辑技术产生突变,以前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK 9)和影响IL-6脱落的基因,以评估其对内皮功能障碍的影响, eTEBV中的泡沫细胞形成以及骨骼肌和心肌束中的炎症。我们会侧写 细胞因子和代谢产物的研究,并证明疾病进展和 生物标志物在常见的抗炎治疗干预的存在下减少, 动脉粥样硬化,并评估运动的影响。同样,在RA肌肉模型中,我们将检查是否 基因变异产生细胞因子谱的改变,影响肌肉功能和对运动的反应; 这些可能指向新的疾病相关生物标志物和治疗靶点。本项目的成果 将为动脉粥样硬化和自身免疫性疾病的体外建模提供一般框架, 基因变异在疾病严重程度和药物开发中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George A Truskey其他文献

George A Truskey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George A Truskey', 18)}}的其他基金

In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria
早衰症体外人体组织工程血管疾病模型
  • 批准号:
    9759965
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
Vascular, Cardiac, and Lung Alveolar Human Microphysiological Systems for SARS-CoV-2 Drug Screening
用于 SARS-CoV-2 药物筛选的血管、心脏和肺泡人体微生理系统
  • 批准号:
    10166020
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
Developing An In Vitro Human Myobundle Model Of Rheumatoid Arthritis
开发类风湿关节炎的体外人体肌束模型
  • 批准号:
    9534005
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease
肌肉和血管疾病微生理模型中的全身炎症
  • 批准号:
    9401783
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease
肌肉和血管疾病微生理模型中的全身炎症
  • 批准号:
    10009489
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria
早衰症体外人体组织工程血管疾病模型
  • 批准号:
    10445145
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease
肌肉和血管疾病微生理模型中的全身炎症
  • 批准号:
    10471015
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria
早衰症体外人体组织工程血管疾病模型
  • 批准号:
    9929937
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria
早衰症体外人体组织工程血管疾病模型
  • 批准号:
    9980460
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:
In Vitro Human Tissue-Engineered Blood Vessel Disease Model of Progeria
早衰症体外人体组织工程血管疾病模型
  • 批准号:
    10622613
  • 财政年份:
    2017
  • 资助金额:
    $ 25.09万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 25.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了